\
&
Contact us
\
&
Contact us
This was 8 months ago
LocationOnline and on April 2nd, 2025 on-site in Toulon (France)
The EURODEF 2025 defence B2B brokerage event aims to strengthen links, and support the creation of winning consortia, between companies from EU countries :
The following themes are addressed: DEFENCE & SECURITY, AERONAUTICS, CYBER-PROTECTION, ENERGY, EXPERIMENTAL AND TEST FACILITIES, HEALTHTECHS, INTEGRATION FACILITIES, MATERIALS, MECHANICS, METALLURGY, MICROELECTRONICS, NAVAL, OPTICS, OPTRONICS, SECURE COMMUNICATIONS, SPACE.
For the event's full agenda, and to register for online or on-site participation, please visit the dedicated EURODEF 2025 B2match platform.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
